TELA Bio

Update in progress

TELA (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

TELA Bio is a commercial-stage medical technology company focused on soft-tissue reconstruction that aims to preserve and restore patient anatomy to improve outcomes. Its OviTex Reinforced Tissue Matrix products support hernia repair and abdominal wall reconstruction, while OviTex PRS targets plastic and reconstructive surgery needs. It also offers OviTex for laparoscopic and robotic procedures. Headquartered in Malvern, PA, it markets products in the United States via a direct sales force. founded in 2012.

Company score

Sentiment: 0.00; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.08; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.23; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.04; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.03; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.02; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive